Ticker Scorecard - APLS Basics Company: Apellis Pharmaceuticals, Inc. IPO Date: November 9, 2017 Sector: Healthcare Industry: Biotech Market Cap: $3.42B Activated in VL: True Average Daily Range Avg Daily Range: $1.05 | 2.84% Avg Daily Range (30 D): $0.65 | 2.18% Avg Daily Range (90 D): $0.65 | 2.19% Institutional Daily Volume Avg Daily Volume: 1.04M Avg Daily Volume (30 D): 1.22M Avg Daily Volume (90 D): 1.85M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 81 Institutional Trades Total Inst.Trades: 7,171 Avg Inst. Trade: $3.26M Avg Inst. Trade (30 D): $4.51M Avg Inst. Trade (90 D): $7.29M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $7.08M Avg Closing Trade (30 D): $10.44M Avg Closing Trade (90 D): $13.72M Avg Closing Volume: 159.88K     News Feb 20, 2025 @ 7:00 AM Apellis and Sobi Announce EMA Validation of Indica... Source: N/A Feb 14, 2025 @ 12:00 PM Apellis Pharmaceuticals to Host Conference Call on... Source: N/A Feb 6, 2025 @ 7:40 PM Investigation Alert: MacroGenics, Apellis Pharmace... Source: Johnson Fistel, Llp Jan 27, 2025 @ 9:00 PM Apellis Receives Approval of SYFOVRE® (pegcetac... Source: N/A Jan 13, 2025 @ 9:46 AM Ophthalmic Drugs Global Market Report 2025: Innova... Source: Researchandmarkets.Com Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.02 $-.46 $-.3 Diluted EPS $-2.02 $-.46 $-.3 Revenue $ 715.22M $ 196.83M $ 199.69M Gross Profit $ $ $ Net Income / Loss $ -250.1M $ -57.45M $ -37.66M Operating Income / Loss $ -223.33M $ -47.28M $ -29.44M Cost of Revenue $ $ $ Net Cash Flow $ -55.26M $ 36.81M $ 34.4M PE Ratio     Splits Mar 19, 2004:   200:1